With Better Targeting Comes Better Outcomes

CEO Ben Lundgren and Chairman Scott Huennekens share the Cytalux technology developed by On Target Laboratories to help identify cancerous lesions during surgery. The emerging market of image-guided therapies will provide surgeons with a substantially higher acuity data set for cancer treatment.
► Subscribe to Our Channel Here
/ mullingsgroup
---------------
LinkedIn: / the-m. .
Website: mullingsgroup.com/
#TheMullingsGroup #TMG